Ketorolac - Neumentum
Alternative Names: Ketorolac (PMB); Ketorolac (PMC); Ketorolac pre mixed bag; Ketorolac tromethamine - Neumentum; NTM 001; NTM 002; NTM 003; Toradol - NeumentumLatest Information Update: 27 Sep 2024
Price :
$50 *
At a glance
- Originator Neumentum
- Developer Mayo Clinic; Neumentum; Nuance Biotech
- Class 2 ring heterocyclic compounds; Carboxylic acids; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrroles; Small molecules
- Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Osteoarthritis; Postoperative pain
Most Recent Events
- 06 Sep 2024 NEMA Research completes a phase III trial in Postoperative pain (In adults) in the US (IV, Infusion) (NCT05324358)
- 28 Jul 2023 Phase-III clinical trials in Osteoarthritis (Treatment-experienced) in USA (Intra-articular) (NCT05992883)
- 02 Mar 2023 Nuance Pharma completes a phase I trial in Postoperative pain (In volunteers, In adults) in Hong Kong (IV) (NCT05382546)